Evidence demonstrates that HIF-1-mediated suppression of FAO is beneficial for cancer progression via reducing ROS production, enhancing glycolysis and activating pro-survival cancer signaling in liver cancer [107]. The gene discussed is HIF1A; the disease is cancer.